.Merck beats profits expectations, raises purchases overview on strong need for top medicines like Keytruda CNBCMerck & Co. (MRK United States) Beats Revenue Forecasts as Keytruda Sales Surge BloombergMerck Inventory: Pharma Titan Posts Solid Outcomes, Yet Expectation Drops Short Investor's Organization DailyMerck Announces Second-Quarter 2024 Financial Results Yahoo FinanceMerck trumps income and also sales expectations amidst Keytruda strength, yet provides blended full-year expectation MarketWatch.